PMID: 19944537

Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer.

van de Velde C J H, Verma S, van Nes J G H, Masterman C, Pritchard K I

Cancer treatment reviews · 2010

Vol. 36, Issue 1, pp. 54-62

View on PubMedDOI

This entry links to third-party literature. For research use only.

Antineoplastic Agents, HormonalAromatase InhibitorsBreast NeoplasmsChemotherapy, AdjuvantFemaleHumansRandomized Controlled Trials as TopicTamoxifen

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.